Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV002968146 | SCV003288397 | uncertain significance | Cobalamin C disease | 2022-09-27 | criteria provided, single submitter | clinical testing | This sequence change replaces proline, which is neutral and non-polar, with threonine, which is neutral and polar, at codon 211 of the MMACHC protein (p.Pro211Thr). This variant is present in population databases (rs192924272, gnomAD 0.1%). This variant has not been reported in the literature in individuals affected with MMACHC-related conditions. Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) has been performed at Invitae for this missense variant, however the output from this modeling did not meet the statistical confidence thresholds required to predict the impact of this variant on MMACHC protein function. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. |
Gene |
RCV003108140 | SCV003761791 | uncertain significance | not provided | 2022-07-28 | criteria provided, single submitter | clinical testing | In silico analysis supports that this missense variant does not alter protein structure/function; Has not been previously published as pathogenic or benign to our knowledge |
Genome- |
RCV002968146 | SCV004178216 | uncertain significance | Cobalamin C disease | 2023-04-11 | criteria provided, single submitter | clinical testing | |
Mayo Clinic Laboratories, |
RCV003108140 | SCV005412096 | uncertain significance | not provided | 2024-05-03 | criteria provided, single submitter | clinical testing |